Orica has reported a FY17 NPAT of $386m with EBIT in-line with consensus $707m. The market is concerned about flat EPS guidance into next year and cost headwinds with increased operating expenses on R&D, IT and at corporate level, to exceed additional$100m+ .
You're not a member! Trial today
